164 related articles for article (PubMed ID: 22104354)
1. High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers.
Bartochowska A; Wierzbicka M; Skowronek J; Leszczyńska M; Szyfter W
Brachytherapy; 2012; 11(2):137-43. PubMed ID: 22104354
[TBL] [Abstract][Full Text] [Related]
2. The role of high-dose-rate and pulsed-dose-rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy.
Bartochowska A; Skowronek J; Wierzbicka M; Leszczyńska M; Szyfter W
Laryngoscope; 2013 Mar; 123(3):657-61. PubMed ID: 22996808
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
5. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
6. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
8. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report of pulsed dose rate brachytherapy in head-and-neck cancer.
Ziemlewski A; Zienkiewicz J; Serkies K; Badzio A
Strahlenther Onkol; 2007 Sep; 183(9):512-6. PubMed ID: 17762926
[TBL] [Abstract][Full Text] [Related]
10. Optimization and it's influence on value of doses in HDR and PDR brachytherapy.
Skowronek J; Zwierzchowski G; Piotrowski T; Milecki P
Neoplasma; 2010; 57(4):369-76. PubMed ID: 20429630
[TBL] [Abstract][Full Text] [Related]
11. Values of biologically equivalent doses in healthy tissues: comparison of PDR and HDR brachytherapy techniques.
Skowronek J; Malicki J; Piotrowski T
Brachytherapy; 2010; 9(2):165-70. PubMed ID: 19879813
[TBL] [Abstract][Full Text] [Related]
12. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
[TBL] [Abstract][Full Text] [Related]
13. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
15. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
16. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
[TBL] [Abstract][Full Text] [Related]
17. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers.
Nag S; Koc M; Schuller DE; Tippin D; Grecula JC
Brachytherapy; 2005; 4(3):217-23. PubMed ID: 16182222
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
[TBL] [Abstract][Full Text] [Related]
20. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]